The invention provides AeSCP-2 polypeptides, polynucleotides encoding
AeSCP-2 polypeptides, and methods for producing such materials by
recombinant techniques. Also provided are methods for utilizing AeSCP-2
polypeptides to screen for compounds exhibiting antagonist or agonist
activity toward AeSCP-2 biological activity, in particular, cholesterol
transport.